Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Uniphar PLC ( (GB:UPR) ) is now available.
Uniphar PLC has announced the publication of its Notice of Annual General Meeting (AGM) for 2025, alongside its annual report for the year ending December 31, 2024. The AGM is scheduled for May 8, 2025, in Dublin, and shareholders are encouraged to participate either in person or by proxy voting. The company has made provisions for shareholders to listen to the AGM proceedings via a conference call, although voting and questions must be submitted in advance. This announcement underscores Uniphar’s commitment to shareholder engagement and transparency in its operations.
More about Uniphar PLC
Headquartered in Dublin, Ireland, Uniphar Group is an international healthcare services business serving over 200 pharmaceutical and medical technology manufacturers across three divisions: Uniphar Pharma, Uniphar Medtech, and Uniphar Supply Chain & Retail. The company operates in Europe, North America, APAC, and MENA, delivering to more than 160 countries. Uniphar aims to improve patient access to medical products by enhancing connectivity between manufacturers and healthcare stakeholders.
YTD Price Performance: 35.67%
Average Trading Volume: 38,808
Technical Sentiment Signal: Strong Sell
Current Market Cap: £601.1M
For a thorough assessment of UPR stock, go to TipRanks’ Stock Analysis page.